04.08.2010
- Sanofi-Aventis has grabbed the headlines with its $18.4 billion bid for Genzyme, but the French drugmaker may be wiser to stick with smaller, bolt-on acquisitions. Sanofi is trying...
04.08.2010
- Sanofi-Aventis investors have urged the drugmaker not to pay more than about $19 billion to land Genzyme, some $10 a share below the price wanted by the U.S. biotech group. Two...
03.08.2010
- Sanofi-Aventis chief executive Chris Viehbacher should aim to land U.S. biotech group Genzyme for around$19 billion to keep his investors on side, according to institutional...
03.08.2010
- Sanofi-Aventis has sent Genzyme a letter indicating its interest in buying the company and the two sides are discussing the offer, a source familiar with the situation said on...
02.08.2010
- Chances are, every big pharmaceutical company is running the numbers and weighing the pros and cons of acquiring Genzyme. French drugmaker Sanofi-Aventis is poised to make a bid...
29.07.2010
- Sanofi-Aventis beat second-quarter earnings expectations as it beefed up sales and tightened its R&D spending, but the French drugmaker gave no hint in its results statement of any...
29.07.2010
- France's Sanofi-Aventis plans to press ahead with a formal offer for Genzyme after its informal overture failed to strike interest, a source familiar with the situation said on...
27.07.2010
- Biotechnology company Genzyme is weighing an informal takeover approach from France's Sanofi-Aventis, but has no current interest in selling the company, a source familiar with the...
